In hepatic disease, elevated levels of serum ALT are more significantly associated with nonalcoholic steatohepatitis than with other causes of hepatitis (alcoholic hepatitis, chronic hepatitis B and C, and autoimmune hepatitis) [15], and it is no wonder that nonalcoholic steatohepatitis has more significant associations with arteriosclerosis and cardiometabolic risk factors than other types of hepatitis. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.